Download
fimmu-12-713420.pdf 3,38MB
WeightNameValue
1000 Titel
  • Involvement of Innate Immune Receptors in the Resolution of Acute Hepatitis B in Woodchucks
1000 Autor/in
  1. Suresh, Manasa |
  2. Li, Bin |
  3. Murreddu, Marta G. |
  4. Gudima, Severin O. |
  5. Menne, Stephan |
1000 Verlag
  • Frontiers Media S.A.
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-22
1000 Erschienen in
1000 Quellenangabe
  • 12:713420
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-24
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fimmu.2021.713420 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340647/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:p>The antiviral property of small agonist compounds activating pattern recognition receptors (PRRs), including toll-like and RIG-I receptors, have been preclinically evaluated and are currently tested in clinical trials against chronic hepatitis B (CHB). The involvement of other PRRs in modulating hepatitis B virus infection is less known. Thus, woodchucks with resolving acute hepatitis B (AHB) after infection with woodchuck hepatitis virus (WHV) were characterized as animals with normal or delayed resolution based on their kinetics of viremia and antigenemia, and the presence and expression of various PRRs were determined in both outcomes. While PRR expression was unchanged immediately after infection, most receptors were strongly upregulated during resolution in liver but not in blood. Besides well-known PRRs, including TLR7/8/9 and RIG-I, other less-characterized receptors, such as IFI16, ZBP1/DAI, AIM2, and NLRP3, displayed comparable or even higher expression. Compared to normal resolution, a 3–4-week lag in peak receptor expression and WHV-specific B- and T-cell responses were noted during delayed resolution. This suggested that PRR upregulation in woodchuck liver occurs when the mounting WHV replication reaches a certain level, and that multiple receptors are involved in the subsequent induction of antiviral immune responses. Liver enzyme elevations occurred early during normal resolution, indicating a faster induction of cytolytic mechanisms than in delayed resolution, and correlated with an increased expression of NK-cell and CD8 markers and cytolytic effector molecules. The peak liver enzyme level, however, was lower during delayed resolution, but hepatic inflammation was more pronounced and associated with a higher expression of cytolytic markers. Further comparison of PRR expression revealed that most receptors were significantly reduced in woodchucks with established and progressing CHB, and several RNA sensors more so than DNA sensors. This correlated with a lower expression of receptor adaptor and effector molecules, suggesting that persistent, high-level WHV replication interferes with PRR activation and is associated with a diminished antiviral immunity based on the reduced expression of immune cell markers, and absent WHV-specific B- and T-cell responses. Overall, the differential expression of PRRs during resolution and persistence of WHV infection emphasizes their importance in the ultimate viral control during AHB that is impaired during CHB.</jats:p>
1000 Sacherschließung
lokal Immunology
lokal Disease Progression [MeSH]
lokal hepatitis B virus
lokal Liver/pathology [MeSH]
lokal Liver/virology [MeSH]
lokal Liver/metabolism [MeSH]
lokal Hepatitis B Virus, Woodchuck/immunology [MeSH]
lokal chronic hepatitis B
lokal innate immune response
lokal Gene Expression [MeSH]
lokal Animals [MeSH]
lokal Marmota [MeSH]
lokal Viral Load [MeSH]
lokal Inflammasomes/metabolism [MeSH]
lokal Liver/immunology [MeSH]
lokal Hepatitis B/veterinary [MeSH]
lokal woodchuck
lokal Hepatitis B, Chronic/veterinary [MeSH]
lokal Transcription Factors/metabolism [MeSH]
lokal Biomarkers [MeSH]
lokal pattern recognition receptors
lokal Immunity, Innate [MeSH]
lokal Receptors, Immunologic/metabolism [MeSH]
lokal acute hepatitis B
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U3VyZXNoLCBNYW5hc2E=|https://frl.publisso.de/adhoc/uri/TGksIEJpbg==|https://frl.publisso.de/adhoc/uri/TXVycmVkZHUsIE1hcnRhIEcu|https://frl.publisso.de/adhoc/uri/R3VkaW1hLCBTZXZlcmluIE8u|https://frl.publisso.de/adhoc/uri/TWVubmUsIFN0ZXBoYW4=
1000 Hinweis
  • DeepGreen-ID: 9b76b0578cc347f09fbed7ff760a093d ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. National Cancer Institute |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Cancer Institute |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6477483.rdf
1000 Erstellt am 2024-05-21T08:55:27.697+0200
1000 Erstellt von 322
1000 beschreibt frl:6477483
1000 Zuletzt bearbeitet 2024-05-22T08:19:28.290+0200
1000 Objekt bearb. Wed May 22 08:19:28 CEST 2024
1000 Vgl. frl:6477483
1000 Oai Id
  1. oai:frl.publisso.de:frl:6477483 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source